Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Testing effectiveness (Phase 2)Ended earlyNCT05363605What this trial is testing[225Ac]-FPI-1966 in Participants With Advanced Solid TumoursWho this might be right forAdvanced Solid TumorHead and Neck Squamous Cell CarcinomaBladder Carcinoma+11 more Fusion Pharmaceuticals Inc. 6
Testing effectiveness (Phase 2)Ended earlyNCT00617929What this trial is testingAntithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantWho this might be right forCancer Masonic Cancer Center, University of Minnesota 12
Early research (Phase 1)Ended earlyNCT03294694What this trial is testingRibociclib + PDR001 in Breast Cancer and Ovarian CancerWho this might be right forMetastatic Hormone-Receptor-Positive (HR+) Breast CancerHER2-Negative Breast CancerMetastatic Epithelial Ovarian Cancer Dana-Farber Cancer Institute 33
Testing effectiveness (Phase 2)Looking for participantsNCT06504147What this trial is testingRadspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking SurgeryWho this might be right forPeritoneal CarcinomatosisOvarian Cancer Oncoinvent Solutions AS 114
Early research (Phase 1)Study completedNCT01256268What this trial is testingCarboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and SolidsWho this might be right forEndometrial CancerOvarian Cancer H. Lee Moffitt Cancer Center and Research Institute 24
Early research (Phase 1)Ended earlyNCT05769959What this trial is testingStudy of RO7515629 in Participants With HLA-G Positive Solid TumorsWho this might be right forRenal Cell CarcinomaNon-small Cell Lung CancerPancreatic Adenocarcinoma+2 more Hoffmann-La Roche 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06544460What this trial is testingSecondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance PatientsWho this might be right forOvarian Cancer Fudan University 94
Testing effectiveness (Phase 2)UnknownNCT03412526What this trial is testingAdoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic OvarianWho this might be right forMetastatic Ovarian Cancer Sheba Medical Center 15
Large-scale testing (Phase 3)Study completedNCT00716976What this trial is testingSodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other MalignancyWho this might be right forBrain TumorCentral Nervous System TumorChildhood Germ Cell Tumor+6 more Children's Oncology Group 131
Not applicableEnded earlyNCT01096381What this trial is testingPotential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid TumorWho this might be right forBreast CancerCardiovascular ComplicationsColorectal Cancer+6 more Vanderbilt-Ingram Cancer Center 8
Testing effectiveness (Phase 2)Looking for participantsNCT05489211What this trial is testingStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)Who this might be right forEndometrial CancerGastric CancerMetastatic Castration-resistant Prostate Cancer+4 more AstraZeneca 454
Testing effectiveness (Phase 2)Study completedNCT01767675What this trial is testingOutcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forOvarian CancerFallopian Tubes CancerPeritoneal Cancer Memorial Sloan Kettering Cancer Center 99
Not applicableActive Not RecruitingNCT06527001What this trial is testingMesenteric Lymph Node Metastasis and Nutritional Status After Bowel Resection for Ovarian CancerWho this might be right forProgression-Free SurvivalOverall SurvivalNutrition Aspect of Cancer Anhui Provincial Hospital 300
Testing effectiveness (Phase 2)Study completedNCT03126110What this trial is testingPhase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic MalignanciesWho this might be right forAdvanced MalignanciesMetastatic Cancer Incyte Biosciences International Sàrl 145
Large-scale testing (Phase 3)Study completedNCT00426257What this trial is testingSecondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian CancerWho this might be right forOvarian Cancer The Netherlands Cancer Institute 242
Testing effectiveness (Phase 2)UnknownNCT04913337What this trial is testingStudy of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesWho this might be right forMesotheliomaGlioblastomaRenal Cell Carcinoma+12 more NGM Biopharmaceuticals, Inc 179
Not applicableStudy completedNCT01459653What this trial is testingMulti-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating FactorWho this might be right forFebrile NeutropeniaCancerBreast Cancer+6 more Sandoz 1,496
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06602063What this trial is testingSurgery for Relapsed Ovarian Cancer in PrecisionWho this might be right forEpithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma Shanghai Gynecologic Oncology Group 33
Early research (Phase 1)Active Not RecruitingNCT06607185What this trial is testingThe Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsWho this might be right forPancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerColorectal Cancer+2 more Eli Lilly and Company 750